Choroid Plexus Volume Distinguishes MOGAD from Multiple Sclerosis on MRI
Personalized briefing
Discovery of the day · Neurology
Comparative Analysis of Choroid Plexus Volume Between MOG Antibody Associated Disease and Multiple Sclerosis
Dear Kelly M Leyden, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology
Discovery of the day
A new MRI-based study demonstrates that choroid plexus volume (CPV) is significantly enlarged in multiple sclerosis (MS) but not in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), providing a potential imaging biomarker to differentiate these two demyelinating conditions. Researchers analyzed 3D-T1-weighted MRI scans from 43 MOGAD patients, 48 MS patients, and 44 healthy controls using Bayesian Gaussian mixture modeling, finding that while MS patients exhibited markedly higher normalized CPV compared to both MOGAD and controls, CPV in MOGAD did not differ from healthy individuals. This finding is directly relevant to your focus on multimodal biomarkers for neurodegenerative disease, as it identifies CPV as a clinically actionable imaging correlate that could enhance diagnostic specificity for MS and, when combined with blood-based proteomic biomarkers, improve the stratification of disease activity and progression in demyelinating disorders.
Novelty
84%
Rigor
82%
Significance
85%
Validity
78%
Clarity
91%
Advertisement
ScientificChina — The Global Marketplace for Scientific and Medical Equipments Start Browsing →
Your briefing is personalized based on your selected fields, keywords, and research interests.
